Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
32,500
Employees32,500
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
32,500
Employees32,500

BMY Key Statistics

Market cap
120.87B
Market cap120.87B
Price-Earnings ratio
12.93
Price-Earnings ratio12.93
Dividend yield
4.32%
Dividend yield4.32%
Average volume
9.96M
Average volume9.96M
High today
$59.81
High today$59.81
Low today
$58.61
Low today$58.61
Open price
$59.16
Open price$59.16
Volume
6.40M
Volume6.40M
52 Week high
$68.64
52 Week high$68.64
52 Week low
$45.27
52 Week low$45.27

Stock Snapshot

As of today, Bristol-Myers Squibb(BMY) shares are valued at $59.13. The company's market cap stands at 120.87B, with a P/E ratio of 12.93 and a dividend yield of 4.32%.

As of 2026-11-20, Bristol-Myers Squibb(BMY) stock has fluctuated between $58.61 and $59.81. The current price stands at $59.13, placing the stock +0.9% above today's low and -1.1% off the high.

The Bristol-Myers Squibb(BMY)'s current trading volume is 6.4M, compared to an average daily volume of 9.96M.

During the past year, Bristol-Myers Squibb(BMY) stock moved between $45.27 at its lowest and $68.64 at its peak.

During the past year, Bristol-Myers Squibb(BMY) stock moved between $45.27 at its lowest and $68.64 at its peak.

BMY News

Simply Wall St 14h
What Does Bristol Myers Squibb Clinical Momentum Mean For Its Growth Story?

Bristol-Myers Squibb (NYSE:BMY) reported broad clinical momentum across hematology and central nervous system programs in November 2026. At the 68th ASH Annual...

What Does Bristol Myers Squibb Clinical Momentum Mean For Its Growth Story?
The Motley Fool 2d
Bristol-Myers Squibb: 3 Key Takeaways for Long-Term Investors

Free Article Explore Premium Services Bristol-Myers Squibb: 3 Key Takeaways for Long-Term Investors A $1.5 billion to $2 billion revenue cliff looms in 2027, ye...

Bristol-Myers Squibb: 3 Key Takeaways for Long-Term Investors

Analyst ratings

60%

of 30 ratings
Buy
33.3%
Hold
60%
Sell
6.7%

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.